Highbridge Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88K | Hold |
1,042
| – | – | ﹤0.01% | 269 |
|
|
2025
Q1 | $7.08K | Hold |
1,042
| – | – | ﹤0.01% | 231 |
|
|
2024
Q4 | $14.4K | Buy |
1,042
+521
| +100% | +$7.19K | ﹤0.01% | 283 |
|
|
2024
Q3 | $7.13K | Hold |
521
| – | – | ﹤0.01% | 310 |
|
|
2024
Q2 | $12.5K | Buy |
+521
| New | +$12.5K | ﹤0.01% | 292 |
|
|
2023
Q4 | – | Sell |
-1,042
| Closed | -$416K | – | 347 |
|
|
2023
Q3 | $416K | Hold |
1,042
| – | – | 0.02% | 135 |
|
|
2023
Q2 | $1.31M | Hold |
1,042
| – | – | 0.06% | 105 |
|
|
2023
Q1 | $1.28M | Hold |
1,042
| – | – | 0.05% | 132 |
|
|
2022
Q4 | $1.27M | Hold |
1,042
| – | – | 0.04% | 217 |
|
|
2022
Q3 | $1.23M | Hold |
1,042
| – | – | 0.02% | 329 |
|
|
2022
Q2 | $1.24M | Sell |
1,042
-3,618
| -78% | -$4.32M | 0.03% | 331 |
|
|
2022
Q1 | $5.53M | Sell |
4,660
-8,536
| -65% | -$10.1M | 0.13% | 225 |
|
|
2021
Q4 | $15.5M | Buy |
+13,196
| New | +$15.5M | 0.34% | 90 |
|